Pylvanainen K | Seppälä Labhttps://www.seppalalab.org/author/pylvanainen-k/Pylvanainen KHugo Blox Builder (https://hugoblox.com)enThu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pngPylvanainen Khttps://www.seppalalab.org/author/pylvanainen-k/Integrative omics approaches to uncover liquid-based cancer-predicting biomarkers in Lynch syndromehttps://www.seppalalab.org/publication/karkkainen-2026-integrative/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/karkkainen-2026-integrative/NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndromehttps://www.seppalalab.org/publication/de-2026-nous-209/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/de-2026-nous-209/Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancerhttps://www.seppalalab.org/publication/nikkola-2025-constrained/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/nikkola-2025-constrained/Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome-A Pilot Studyhttps://www.seppalalab.org/publication/sievanen-2024-circulating/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/sievanen-2024-circulating/Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databasehttps://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivityhttps://www.seppalalab.org/publication/kansikas-2023-tumor-independent/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/kansikas-2023-tumor-independent/Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-uphttps://www.seppalalab.org/publication/mathers-2022-cancer/Sat, 01 Jan 2022 00:00:00 +0000https://www.seppalalab.org/publication/mathers-2022-cancer/Body Weight, Physical Activity, and Risk of Cancer in Lynch Syndromehttps://www.seppalalab.org/publication/sievanen-2021-body/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/sievanen-2021-body/No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Studyhttps://www.seppalalab.org/publication/dominguez-valentin-2021-no/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2021-no/Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database reporthttps://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database reporthttps://www.seppalalab.org/publication/seppala-2021-uptake/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2021-uptake/Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndromehttps://www.seppalalab.org/publication/engel-2020-associations/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/engel-2020-associations/Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Databasehttps://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Databasehttps://www.seppalalab.org/publication/dominguez-valentin-2020-correction/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2020-correction/Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive studyhttps://www.seppalalab.org/publication/kalamo-2020-factors/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/kalamo-2020-factors/Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/seppala-2019-lack/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2019-lack/Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/dominguez-valentin-2019-survival/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2019-survival/Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Databasehttps://www.seppalalab.org/publication/moller-2018-cancer/Mon, 01 Jan 2018 00:00:00 +0000https://www.seppalalab.org/publication/moller-2018-cancer/Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generationshttps://www.seppalalab.org/publication/seppala-2017-uptake/Sun, 01 Jan 2017 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2017-uptake/